Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Santyl vs. Hydrogel for Debridement of Inflamed Diabetic Foot Ulcers
NCT01143727Phase 4Completed
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Jul 2010
- Primary completion
- Oct 2011
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of collagenase clostridium histolyticum in diabetic foot ulcer (DFU) (2 arms), sponsored by Healthpoint Biotherapeutics. Primary endpoint: Wound Appearance at 28 days. Started Jul 2010; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01143727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143727.